Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr

Plethico Pharma has announced its foruth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.

May 16, 2011 / 12:05 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Plethico Pharma has announced its fourth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.

Its PAT was down 23% at Rs 55 crore versus Rs 71 crore.

Its EBITDA margin at 20.1% versus 21.7%.

first published: May 16, 2011 12:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347